PATENT CLAIM ANALYSIS

Application Number: 16053006
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "454000"]

Abstract:
Described herein are Δ 9 -THC prodrugs, methods of making Δ 9 -THC prodrugs, formulations comprising Δ 9 -THC prodrugs and methods of using Δ 9 -THC. One embodiment described herein relates to the transdermal administration of a Δ 9 -THC prodrug for treating and preventing diseases and/or disorders.

Claim (Index 1):
A compound having the formula: wherein R 1  is selected from an ester, a carbonate, a carbamate and a phosphate.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.65625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14620016', '13555741', '12326036', '15374281', '12182974']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7961338808343579
- 35 USC 102 Novelty (BERT): 0.5585677276725622
- Combined Prediction Score: 0.7723772655181783
- Mean Citation Score: 402.690652
- Max Citation Score: 434.60895
- Similarity Product: 367.8312132940471

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test